Related Experiment Videos
Atypical hemorrhagic bullous pyoderma gangrenosum
I K Altunay1, S A Sezgin, U Ileri
1Department of Dermatology, Sişli Etfal Training and Research Hospital, Istanbul, Turkey. Goldmoon3@mynet.com
International Journal of Dermatology
|September 14, 2001
Summary
This case study highlights bullous pyoderma gangrenosum, a rare ulcerative skin condition. Prompt diagnosis and treatment with systemic corticosteroids led to rapid healing and complete recovery.
Area of Science:
- Dermatology
- Immunodermatology
- Wound Healing
Background:
- Pyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis characterized by painful ulcerative lesions.
- Bullous PG is a rare variant presenting with vesicles and bullae that rupture into ulcers.
Observation:
- A 55-year-old woman presented with a nonhealing leg wound, progressing to ulcers and bullae despite various treatments, including hyperbaric oxygen and skin grafting.
- Dermatologic examination revealed extensive necrotic ulcers, hemorrhagic bullae, and pustules.
- Histopathology showed dense neutrophilic infiltrate, vascular damage, and extravasated erythrocytes.
Findings:
- Clinical and histopathologic findings confirmed a diagnosis of bullous pyoderma gangrenosum.
- Treatment with high-dose prednisolone (80 mg/day) resulted in rapid epithelialization within 2 months.
- A maintenance dose of 20 mg/day prednisolone led to complete improvement in 8 months with no observed side effects.
Implications:
- This case underscores the importance of considering bullous pyoderma gangrenosum in patients with rapidly progressing ulcerative skin lesions.
- Systemic corticosteroid therapy is an effective treatment for bullous pyoderma gangrenosum, leading to significant wound healing.
- Early diagnosis and appropriate management can prevent extensive tissue damage and improve patient outcomes in this rare condition.